Jeff Yass’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.4K Buy
62,600
+46,000
+277% +$66.9K ﹤0.01% 12626
2026
Q1
$24.1K Sell
16,600
-47,100
-74% -$74.7K ﹤0.01% 12820
2025
Q4
$87.9K Sell
63,700
-9,600
-13% -$20.1K ﹤0.01% 11523
2025
Q3
$200K Buy
73,300
+50,900
+227% +$181K ﹤0.01% 10996
2025
Q2
$78.2K Buy
22,400
+5,700
+34% +$22.5K ﹤0.01% 11921
2025
Q1
$61.5K Buy
+16,700
New +$61K ﹤0.01% 11788
2021
Q4
Sell
-24,200
Closed -$159K 13877
2021
Q3
$159K Buy
+24,200
New +$232K ﹤0.01% 11741

Other funds holding STIM

Jeff Yass's STIM Position: Q2 2026 in Review

Jeff Yass increased its Neuronetics (STIM) stake by 115% in Q2 2026, buying an estimated $144K and bringing the position to 185,753 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #11548.

Jeff Yass first reported a position in STIM in Q1 2021 and has held it in 17 quarters since. The position peaked at $2.8M in Q1 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Jeff Yass held 185,753 shares of Neuronetics worth $241K as of Q2 2026.
  • Jeff Yass bought 99,272 Neuronetics shares in Q2 2026, an estimated $144K.
  • Neuronetics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11548 holding.
  • Jeff Yass first reported a position in Neuronetics in Q1 2021 and has held it in 17 quarters since.
  • Jeff Yass's Neuronetics position peaked at $2.8M in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.